Delivery Order SPE2DR25D2003-SPE2DR26FQ96L
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,653.21 to AmerisourceBergen Drug Corp for the supply of Viberzi 100 mg tablets (60-count units) under a firm fixed-price contract type. The award, issued on November 14, 2025, with an ultimate completion date of November 17, 2025, represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical products will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order valued at $2,711.03 to AmerisourceBergen Drug Corp for 60 tablets of Viberzi 100 mg, a pharmaceutical product for gastrointestinal treatment. This competitively awarded, non-set-aside contract employs firm fixed pricing and carries an ultimate completion date of May 19, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded a delivery order valued at $2,276.84 to AmerisourceBergen Drug Corp for the supply of Viberzi 100 mg tablets (60-count). This non-competitive, firm fixed-price delivery order is scheduled for completion by June 30, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, will fulfill this pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Viberzi 100 mg tablets (60-count units) valued at $3,764.82 with a firm fixed price structure. The award was made on June 2, 2025, with an ultimate completion date of June 3, 2025, and represents a non-set-aside competitive procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on May 27, 2025, for the supply of Viberzi 100 mg tablets (60-count) with a contract value of $1,480.32. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of May 28, 2025. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award represents a continuation of AmerisourceBergen's substantial role as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,777.86 to AmerisourceBergen Drug Corp for 60 tablets of Viberzi 75 mg on October 21, 2025, with an ultimate completion date of October 22, 2025. This firm fixed-price contract is non-competitive and was awarded without a set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 1, 2025, for the supply of Viberzi 100mg tablets (60-count package) with a ceiling value of $3,415.20. This firm fixed-price delivery order, with an ultimate completion date of September 2, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $2,755.35 to AmerisourceBergen Drug Corp for 60 tablets of Viberzi 75 mg, a pharmaceutical product for gastrointestinal disorders. The award, issued on November 14, 2025, with an ultimate completion date of November 17, 2025, employs firm fixed-price pricing under a non-set-aside, competitively awarded contract. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,960.49 to AmerisourceBergen Drug Corp for the supply of Viberzi 100 mg tablets (60-count) on July 15, 2025, with completion scheduled for July 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,415.26 to AmerisourceBergen Drug Corp for the supply of Viberzi 100 mg tablets (60-count package). This firm fixed-price, competitively awarded delivery order was issued on August 7, 2025, with an ultimate completion date of August 8, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. The contract represents a continuation of...
- SPE2DR25D2003Indefinite Delivery Contract
- SPE2DR25D2003-SPE2DR26FQ96LDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Viberzi 100 mg at a ceiling value of $1,132.57 under firm fixed pricing. This non-set-aside delivery order, dated November 14, 2025, with an ultimate completion date of November 17, 2025, represents a routine pharmaceutical supply transaction supporting federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical supply vehicle running through December 2026. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for military and veteran healthcare systems through this comprehensive contract vehicle, which enables the company to supply pharmaceuticals, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's portfolio of DLA contracts demonstrates its capability to fulfill diverse federal medical supply requirements through open competition, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 11/14/25 |